azd-6918
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00733031)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545298 ↗
Also known as
- azd6918
- azd-6918
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00733031 | Phase 1 | Aug 1, 2008 | AstraZeneca, SCRI Development Innovations, University of Colorado, Denver |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 1 | 1 | 1 | 2008 |
| SCRI Development Innovations | For profit | 1 | 0 | 1 | 2008 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1